Alan Colowick
Impact in
- Hematology top 1%
- Erythropoietin and Anemia Treatment
- Iron Metabolism and Disorders
- Hemophilia Treatment and Research
- Biochemistry top 2%
- Blood transfusion and management
Papers in
- Hematology 14
- Erythropoietin and Anemia Treatment 12
- Iron Metabolism and Disorders 5
- Hemophilia Treatment and Research 2
- Platelet Disorders and Treatments 2
-
- Pharmacological Effects and Toxicity Studies 4
- Co-authors
- John A. Glaspy (8 shared papers)Giuseppe Rossi (3 shared papers)Glen R. Justice (4 shared papers)Rhonda L. Bohn (2 shared papers)Bruce M. Ewenstein (2 shared papers)Jerry Avorn (2 shared papers)N. Simon Tchekmedyian (3 shared papers)Lee S. Schwartzberg (4 shared papers)
- Journals
- British Journal of Cancer (4 papers)European Journal of Cancer (4 papers)Cancer (3 papers)Blood (3 papers)The Journal of Urology (1 paper)
- Partner nations
- United StatesCanadaAustria
In The Last Decade
Alan Colowick
19 papers receiving 747 citations
Peers
Comparison fields: 5 of 57
- Hematology 702
- Biochemistry 194
- Health Informatics 18
- Genetics 116
- Nephrology 63
Countries citing papers authored by Alan Colowick
This map shows the geographic impact of Alan Colowick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Colowick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Colowick more than expected).
Fields of papers citing papers by Alan Colowick
This network shows the impact of papers produced by Alan Colowick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Colowick. The network helps show where Alan Colowick may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Colowick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 138 | |
| 2 | 2003 | 119 | |
| 3 | 2000 | 84 | |
| 4 | 2001 | 69 | |
| 5 | 2003 | 69 | |
| 6 | 2001 | 62 | |
| 7 | 2003 | 62 | |
| 8 | 2004 | 39 | |
| 9 | 2001 | 32 | |
| 10 | 2002 | 26 | |
| 11 | 2000 | 26 | |
| 12 | 2001 | 17 | |
| 13 | Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis. | 2002 | 16 |
| 14 | 2007 | 12 | |
| 15 | 2001 | 11 | |
| 16 | Every-2-Week Darbepoetin Alfa Is Comparable to rHuEPO in Treating Chemotherapy-Induced Anemia | 2002 | 10 |
| 17 | A randomized, blinded, placebo-controlled, phase II, dose-finding study of ARANESP (TM) in patients with lymphoproliferative malignancies. | 2000 | 4 |
| 18 | 2006 | 1 | |
| 19 | 2007 | 1 |
About Alan Colowick
Alan Colowick is a scholar working on Hematology, Pediatrics, Perinatology and Child Health, Oncology, Biochemistry and Immunology, having authored 19 papers that have together received 798 indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (12 papers), Iron Metabolism and Disorders (5 papers), Pharmacological Effects and Toxicity Studies (4 papers), Blood transfusion and management (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Hemophilia Treatment and Research (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Hematology (702 citations), Biochemistry (194 citations), Health Informatics (18 citations), Genetics (116 citations) and Nephrology (63 citations). Alan Colowick has collaborated with scholars based in United States, Canada and Austria. Frequent co-authors include John A. Glaspy, Giuseppe Rossi, Glen R. Justice, Rhonda L. Bohn, Bruce M. Ewenstein, Jerry Avorn, N. Simon Tchekmedyian, Lee S. Schwartzberg, Gregory Rossi and J. Keßler. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, Cancer, Blood and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.